Johanna Mangana
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.
Kostner L, Cerminara S, Pamplona G, Maul J, Dummer R, Ramelyte E, Mangana J, Wagner N, Cozzio A, Kreiter S, Kogler A, Streit M, Wysocki A, Zippelius A, Läubli H, Navarini A, Maul L. Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown. Cancers (Basel) 2022; 14
10.05.2022Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.
10.05.2022Cancers (Basel) 2022; 14
Kostner Lisa, Cerminara Sara Elisa, Pamplona Gustavo Santo Pedro, Maul Julia-Tatjana, Dummer Reinhard, Ramelyte Egle, Mangana Johanna, Wagner Nikolaus, Cozzio Antonio, Kreiter Saskia, Kogler Angelika, Streit Markus, Wysocki Anja, Zippelius Alfred, Läubli Heinz, Navarini Alexander, Maul Lara Valeska
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
Wagner N, Schraag A, Klumpp B, Hoetzenecker W, Berking C, Richtig E, Ziemer M, Mangana J, Terheyden P, Loquai C, Nguyen V, Gebhardt C, Meier F, Diem S, Cozzio A, Flatz L, Röcken M, Garbe C, Gassenmaier M, Weide B, Leiter U, Lenders M, Kühl K, Reinhardt L, André F, Dudda M, Ring N, Ebel C, Stäger R, Zellweger C, Lang R, Paar M, Gussek P, Richtig G, Stürmer S, Kimeswenger S, Oellinger A, Forschner A, Eigentler T. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study. J Immunother Cancer 2021; 9
01.01.2021Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
01.01.2021J Immunother Cancer 2021; 9
Wagner Nikolaus, Schraag Amadeus, Klumpp Bernhard, Hoetzenecker Wolfram, Berking Carola, Richtig Erika, Ziemer Mirjana, Mangana Johanna, Terheyden Patrick, Loquai Carmen, Nguyen Van Anh, Gebhardt Christoffer, Meier Friedegund, Diem Stefan, Cozzio Antonio, Flatz Lukas, Röcken Martin, Garbe Claus, Gassenmaier Maximilian, Weide Benjamin, Leiter Ulrike, Lenders Max M, Kühl Kathrin, Reinhardt Lydia, André Fiona, Dudda Milena, Ring Natalie, Ebel Chiara, Stäger Ramon, Zellweger Caroline, Lang Roland, Paar Michael, Gussek Philipp, Richtig Georg, Stürmer Suzan H, Kimeswenger Susanne, Oellinger Angela, Forschner Andrea, Eigentler Thomas K
Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
Sönnichsen A, Cozzio A, Hoetzenecker W, Schmid-Grendelmeier P, Petrausch U, Chang Y, Desislava I, Mehra T, Kerl K, Mangana J, Saulite I, Guenova E. Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome. J Dermatolog Treat 2016; 27:436-8.
10.02.2016Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
10.02.2016J Dermatolog Treat 2016; 27:436-8
Sönnichsen Astrid, Cozzio Antonio, Hoetzenecker Wolfram, Schmid-Grendelmeier Peter, Petrausch Ulf, Chang Yun-Tsan, Desislava Ignatova, Mehra Tarun, Kerl Katrin, Mangana Johanna, Saulite Ieva, Guenova Emmanuella